Brexanolone, which will be marketed under the brand name Zulresso, is the first pharmacotherapy approved for treating postpartum depression.
Initial self-reported depression and insomnia prior to the diagnosis and treatment of obstructive sleep apnea with continuous positive airway...
Major depressive disorder and bipolar disorder appear to be associated with different underlying brain structures.
Under the FDA-required REMS, prescribers must complete specific training; the drug must be adminstered in office to allow for patient monitoring...
Compared to non-ICU visitors, patients had greater risk of developing new chronic conditions after discharge.
Dr. Igor Galynker is back to talk with Dr. Lorenzo Norris about suicide.
ROCKVILLE, MD –
Mental Health Care Practice
Overemphasizing Communities in the National Strategy for Preventing Veteran Suicide Could Undercut VA Successes
In June 2018, the US Department of Veterans Affairs (VA) issued its National Strategy for Preventing Veteran Suicide, 2018-2028. Its...
AUSTIN, TEX. – Potential mass shootings that get disrupted offer lessons for prevention.